PHILADELPHIA – Treatment with Entyvio for immunotherapy-induced enterocolitis demonstrated favorable outcomes and a good safety profile, according to data presented at the American College of Gastroenterology Annual Meeting.
“Immunotherapy is a treatment for a vast number of malignancies with great success in achieving response,” Hamzah Abu-Sbeih, MD, from the University of Texas MD Anderson Cancer Center, said during his presentation. “However, it is common for immunotherapy success to be limited by adverse events with enterocolitis being among the more common

Source link